ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.
Vicent S, López-Picazo JM, Toledo G, Lozano MD, Torre W, Garcia-Corchón C, Quero C, Soria JC, Martín-Algarra S, Manzano RG, Montuenga LM.
Vicent S, et al. Among authors: montuenga lm.
Br J Cancer. 2004 Mar 8;90(5):1047-52. doi: 10.1038/sj.bjc.6601644.
Br J Cancer. 2004.
PMID: 14997206
Free PMC article.